RenovoRx Inc
NASDAQ:RNXT

Watchlist Manager
RenovoRx Inc Logo
RenovoRx Inc
NASDAQ:RNXT
Watchlist
Price: 0.9 USD -3.23% Market Closed
Market Cap: 33m USD

Wall Street
Price Targets

RNXT Price Targets Summary
RenovoRx Inc

Wall Street analysts forecast RNXT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RNXT is 5.74 USD with a low forecast of 3.03 USD and a high forecast of 13.13 USD.

Lowest
Price Target
3.03 USD
237% Upside
Average
Price Target
5.74 USD
538% Upside
Highest
Price Target
13.13 USD
1 358% Upside
RenovoRx Inc Competitors:
Price Targets
ALKS
Alkermes Plc
56% Upside
9926
Akeso Inc
52% Upside
ADMA
ADMA Biologics Inc
32% Upside
GLPG
Galapagos NV
10% Upside
GOSS
Gossamer Bio Inc
155% Upside
IMTX
Immatics NV
82% Upside
SLS
Sellas Life Sciences Group Inc
164% Upside
URGN
Urogen Pharma Ltd
52% Upside

Revenue
Forecast

Revenue Estimate
RenovoRx Inc

The compound annual growth rate of RenovoRx Inc's revenue for the next 4 years is 497%.

N/A
Past Growth
497%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
RenovoRx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
RenovoRx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNXT's stock price target?
Price Target
5.74 USD

According to Wall Street analysts, the average 1-year price target for RNXT is 5.74 USD with a low forecast of 3.03 USD and a high forecast of 13.13 USD.

What is RenovoRx Inc's Revenue forecast?
Projected CAGR
497%

The compound annual growth rate of RenovoRx Inc's revenue for the next 4 years is 497%.

Back to Top